Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1128 of 5804
-
New combo therapy aims to shrink Hard-to-Treat sarcomas
Disease control Recruiting nowThe investigators hypothesize that zanzalintinib in combination with ipilimumab and nivolumab will be well tolerated and serve as a potential therapeutic strategy in metastatic soft tissue sarcoma (mSTS) including myxofibrosarcoma, undifferentiated pleomorphic sarcoma, dedifferen…
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Sweat before you talk: new study tests Exercise-Boosted therapy for depression
Symptom relief Recruiting nowThis study investigates the effects of intentionally sequencing aerobic exercise immediately prior to cognitive behavioral therapy (CBT) to determine its effects on mechanisms of CBT (i.e., working alliance, behavioral activation). To assess the utility of this treatment augmenta…
Phase: NA • Sponsor: University of Wisconsin, Madison • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
New disc implant aims to ease chronic neck pain
Disease control Not yet recruitingA multicenter, prospective, historically controlled study to evaluate the safety and effectiveness of the Triadyme-C device in comparison to other approved TDRs in the treatment of symptomatic cervical disc disease (SCDD) in subjects who are symptomatic at only a single level fro…
Phase: NA • Sponsor: Dymicron • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Heated vs. sprayed chemo: which works better for belly cancer?
Disease control Recruiting nowThis research study aims to improve the treatment of Peritoneal Carcinomatosis (PC), a condition where cancer spreads within the abdomen. Patients with PC often experience significant pain and nutritional problems. Currently, there isn't a standard treatment approach, and doctors…
Phase: PHASE2 • Sponsor: Patrick Wagner, MD, FACS • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New device could cut stroke risk in kidney patients on dialysis
Disease control Not yet recruitingObjectives: This pilot study aims to evaluate the safety and efficacy of left atrial appendage occlusion (LAAO) in dialysis patients and atrial fibrillation (AF) to establish a novel stroke prevention strategy and determine an optimal post-occlusion antithrombotic regime. Page 3 …
Sponsor: Prince of Wales Hospital, Shatin, Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Could a blood clot improve penile surgery in boys?
Disease control Recruiting nowHypospadias is a common congenital condition in boys in which the opening of the urethra is located on the underside of the penis. Distal hypospadias is the most common form and is usually treated surgically using tubularized incised plate (TIP) urethroplasty. In boys with an unf…
Phase: NA • Sponsor: National Children's Medical Center, Uzbekistan • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
AI could help doctors personalize treatment for autoimmune hepatitis
Knowledge-focused OngoingThe 5th International Autoimmune Hepatitis Group (IAIHG) research workshop emphasized the integration of large clinical cohorts with artificial intelligence (AI) for enhanced prediction of therapy responses and outcomes in Autoimmune Hepatitis (AIH). This project aims to develop …
Sponsor: Hannover Medical School • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
New balloon could open blocked heart arteries without a stent
Disease control Recruiting nowThis prospective, multicenter, post-market observational study aims to evaluate the safety and effectiveness of the crystalline sirolimus-coated balloon (SeQuent® Sirolimus-Coated Balloon) for the treatment of coronary artery disease in routine clinical practice. Consecutive, uns…
Sponsor: Fundación Interhospitalaria para la Investigación Cardiovascular FIC • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Sound waves zapping tumors: new hope for pancreatic cancer?
Disease control Recruiting nowThis is a feasibility, safety, tolerability, and efficacy research study of an investigational device called "Suizenji", an ultrasound-guided high-intensity focused ultrasound (HIFU) therapy system for the treatment of unresectable pancreatic ductal adenocarcinoma. Focused ultras…
Phase: EARLY_PHASE1 • Sponsor: SONIRE Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New vibration therapy could supercharge stroke rehab walking gains
Symptom relief Recruiting nowRobotic-assisted gait training (RAGT) devices, such as the Lokomat®, are commonly used to support gait rehabilitation by enabling repetitive, task-specific walking movements. The functional proprioceptive stimulation (FPS) device Vibramoov® represents a novel technology designed …
Phase: NA • Sponsor: Ludwig Boltzmann Institute for Arthritis and Rehabilitation • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
New pill shows promise for rare lymphoma – no chemo needed yet
Disease control Recruiting nowThis is a single-arm, multicenter, prospective, phase II study. The primary objective is to assess the efficacy and safety of orelabrutinib in treatment-naïve patients with marginal zone lymphoma.
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Can a phone app ease depression and anxiety? massive new study aims to find out
Symptom relief Not yet recruitingThis study aims to implement and evaluate a technological intervention called CONEMO to treat depressive symptoms, anxiety, and insomnia in adults who use primary health care services. The effectiveness of this intervention has already been proven in previous research, specifical…
Phase: NA • Sponsor: University of Sao Paulo General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
New shot aims to block tetanus after cuts and wounds
Prevention Not yet recruitingStudy sites were selected from hospitals across diverse regions of China. Approximately 6,000 participants who require passive immunization against tetanus due to various injuries (including those with severe wounds or heavily contaminated injuries) will be enrolled. Per clinical…
Sponsor: Zhuhai Trinomab Pharmaceutical Co., Ltd. • Aim: Prevention
Last updated Jun 27, 2026 08:11 UTC
-
AI reads your ECG to catch silent heart danger before surgery
Diagnosis Not yet recruitingThis study is a prospective, open-label, randomized controlled trial designed to evaluate a new artificial intelligence (AI) tool for heart monitoring. Researchers will use an AI-enabled electrocardiography (ECG) system to screen patients before they undergo surgery. The main goa…
Phase: NA • Sponsor: Taipei Veterans General Hospital, Taiwan • Aim: Diagnosis
Last updated Jun 27, 2026 08:12 UTC
-
Can antibodies shield newborns from HIV? early trial begins
Prevention Recruiting nowThe purpose of this study is to evaluate the safety and pharmacokinetics (PK) of the potent, broadly neutralizing anti-HIV monoclonal antibodies (mAb) PGT121.414.LS alone and in combination with VRC07-523LS soon after birth in infants exposed to HIV-1.
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Prevention
Last updated Jun 27, 2026 12:39 UTC
-
New 'Y Incision' heart surgery could let doctors fit larger valves in small hearts
Disease control Recruiting nowAbstract Background: Aortic valve replacement (AVR) is crucial for patients with severe aortic valve disease. However, managing those with a small aortic annulus (SAA, i.e., annulus diameter \< 22 mm) is challenging because implanting a small prosthesis can result in patient-pros…
Phase: NA • Sponsor: willner nadav MD • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
New drug combo aims to shrink ovarian tumors in Hard-to-Treat patients
Disease control Not yet recruitingThis study evaluates the efficacy and safety of Zeprumetostat in combination with Fuzuloparib for the treatment of patients with advanced or recurrent ovarian epithelial carcinoma, with the primary endpoint being Objective Response Rate (ORR).
Phase: PHASE2 • Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New hope for tough leukemia? early trial combines three drugs
Disease control Recruiting nowIMAGINE is a two-part trial to evaluate the safety and preliminary efficacy of imetelstat in combination with azacitidine with or without venetoclax in patients with relapsed or refractory AML. The trial will consist of a safety run-in phase (Part A) employing a 3+3 design to mon…
Phase: PHASE1 • Sponsor: Douglas Tremblay • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Freeze your pain away: new procedure before knee surgery shows promise
Symptom relief Recruiting nowApproximately 20-30% of patients experience persistent pain after a Total Knee Arthroplasty (TKA). This study investigates whether percutaneous cryoneurolysis of genicular nerves can reduce pain and improve physical function when performed at least 24 hours before surgery. Partic…
Phase: NA • Sponsor: Attikon Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Could placental wraps heal stubborn ulcers? new trial begins
Disease control Recruiting nowThe study is a multicenter, prospective, controlled modified multi-platform trial assessing the efficacy of human placental membrane products and standard of care in the management of nonhealing diabetic foot ulcers and venous leg ulcers.
Phase: PHASE4 • Sponsor: BioLab Holdings • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC